Xtant Medical Holdings Inc’s filing revealed that its 10% Owner ORBIMED ADVISORS LLC unloaded Company’s shares for reported $30.71 million on Apr 10 ’25. In the deal valued at $0.42 per share,73,114,592 shares were sold. As a result of this transaction, ORBIMED ADVISORS LLC now holds 0 shares worth roughly $0.0.
BTIG Research initiated its Xtant Medical Holdings Inc [XTNT] rating to a Buy in a research note published on December 05, 2023; the price target was $2. A number of analysts have revised their coverage, including Maxim Group’s analysts, who remained covering the stock and in mid November has reiterated a ‘”a Buy”‘ rating for it. Maxim Group also remained covering XTNT and reiterated its “Buy” recommendation on February 14, 2018.
Price Performance Review of XTNT
On Monday, Xtant Medical Holdings Inc [AMEX:XTNT] saw its stock jump 17.49% to $0.74. Over the last five days, the stock has gained 25.25%. Xtant Medical Holdings Inc shares have risen nearly 18.24% since the year began. Nevertheless, the stocks have risen 66.82% over the past one year. While a 52-week high of $0.83 was reached on 06/30/25, a 52-week low of $0.33 was recorded on 04/10/25.
Levels Of Support And Resistance For XTNT Stock
The 24-hour chart illustrates a support level at 0.6791, which if violated will result in even more drops to 0.6193. On the upside, there is a resistance level at 0.7884. A further resistance level may holdings at 0.8379.
How much short interest is there in Xtant Medical Holdings Inc?
A steep rise in short interest was recorded in Xtant Medical Holdings Inc stocks on 2025-06-13, growing by 12569.0 shares to a total of 56479.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 43910.0 shares. There was a rise of 22.25%, which implies that there is a positive sentiment for the stock.
